Schedule 13G ownership disclosure

PROVECTUS PHARMACEUTICAL INCORPORATED

Security class unavailable · CUSIP: 74373P108

Event date: 2024-08-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-032465
Form type
SC 13G
Filer
Morris Jeffrey Allen
CIK
CIK 1959175
Filed
Aug 14, 2024
Reporting period
Aug 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub